New hope for infertile women with adenomyosis: drug may boost live birth rates
NCT ID NCT07162961
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study tests whether nintedanib, a drug that reduces scar-like tissue, can help women with adenomyosis have a baby. About 328 women aged 20-38 with infertility and frozen embryos will receive either standard hormone therapy plus nintedanib or hormone therapy alone for three months before embryo transfer. The main goal is to see if nintedanib increases the number of live births.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOMYOSIS OF UTERUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.